New Jersey Law Journal names Parvin K. Aminolroaya among the “Top Women in Law”

Seeger Weiss LLP is proud to announce that partner Parvin K. Aminolroaya has been recognized among New Jersey Law Journal’s “Top Women in Law.” “I’m honored to be recognized alongside these incredibly accomplished lawyers,” says Aminolroaya. Only twenty were selected, among them law professors, in-house counsel, and members of the U.S. Attorney’s Office for the […]

October 23, 2020

Parvin Aminolroya

Seeger Weiss LLP is proud to announce that partner Parvin K. Aminolroaya has been recognized among New Jersey Law Journal’s “Top Women in Law.”

“I’m honored to be recognized alongside these incredibly accomplished lawyers,” says Aminolroaya. Only twenty were selected, among them law professors, in-house counsel, and members of the U.S. Attorney’s Office for the District of New Jersey.

A litigator at Seeger Weiss for more than a decade, Aminolroaya has brought her extensive background in class action consumer and mass tort matters to bear on many of the biggest cases before the country. Her work includes serving in key trial, discovery, and expert development roles, including discovery negotiations, depositions, expert development, brief writing, and trial preparation. She has represented a wide spectrum of plaintiffs in such significant matters as litigation against makers of opioid drugs, representing counties and municipalities whose health and hospital systems have been severely tested by the epidemic of drug abuse; litigation against 3M over allegations that the manufacturer sold defective earplugs both to the military for use in battle situations and to civilians for high noise exposure situations; and litigation against Volkswagen and other carmakers for disguising the actual emission levels of their diesel engine cars, resulting several multi-billion dollar settlements; among others.

“I find my work so meaningful,” Aminolroaya says. “Cases like In re National Prescription Opiate Litigation seek to recover funds for state and local governments addressing the harm to their communities caused by defendants’ conduct. It’s work that impacts entire country.”

New Jersey Law Journal will be publishing a special supplement later this year that will spotlight the honorees, their accomplishments, and their insights. New Jersey Law Journal last published a “Top Women in Law” feature in 2018.

No aspect of this advertisement has been approved by the Supreme Court of New Jersey or a court or authority of any jurisdiction.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More